Service
Resources
News
CER
About

Subscribe

Strategy Consulting

Market Entry Strategy
Regulatory Strategy
Clinical Strategy
China Localization Strategy
Hainan Urgent Use Pathway
Innovation Pathway
Fast Track Pathway
Digital Health Consulting

Registration Affairs

Pre-market Registration
Modification Registration
Renewal Registration
Request for Classification
Legal Agent Representation
NMPA Expert Panel Meeting
NMPA Supplemental Notice

Quality Assurance

Postmarket Surveillance Compliance (IFU, Label, GSP)
Adverse Event Reporting
Recall Handling
Periodic Risk Evaluation Report
Annual QMS Self-Inspection Report
NMPA Inspections & Mock-Audit
QMS Establishment/Audit/Remediation
QA Gap Analysis
Factory Audit
Unique Device Identifier

Device Testing

China Local Type Testing
Device Modification Compliance Testing
Biocompatibility Testing
EMC Testing

Clinical Research Organization (CRO)

Clinical Trials/Research
Real-World Study
China CER & MDR CER
Clinical Evaluation Feasibility Assessment

Customized Training

China Regulatory Training
China QMS Training
China GCP Training
China Localization Training
Periodic Regulatory Updates Training

Other Services

Translation
Patent & Trademark
Distributor Evaluation & Audit
KOL Interview/Consultation
Investment
Global regulatory services

Service
Resources
News
About
CER
Subscribe

CN
US

Home

8. Usage Of Real-World Evidence For Medical Devices China Vs. US

2022-12-20

Suggested Reading

China NMPA Newsletter - July 2024
Summary of 2023 China NMPA Medical Device Registration Work Report
China NMPA Newsletter - June 2024
China NMPA Implements Revised Classification Catalog for In Vitro Diagnostic Reagents
China NMPA Newsletter - February 2024
China NMPA Newsletter - January 2024
China's NMPA Approves 277 Innovative Medical Devices
China NMPA Newsletter - April 2024
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
How is the endotoxin limit for wound dressing products determined?
NMPA medical device classification results in 2024
China NMPA Released Plan for Annual Medical Device Quality Inspections

Twitter Linkedin

United States

Email: info@bradyknowsmedical.com
Phone: +86 18600392020

China

Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7